IMMUNOMEDICS INC
10-K, EX-27, 2000-09-28
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: IMMUNOMEDICS INC, 10-K, EX-23, 2000-09-28
Next: FLIGHTSERV COM, 10KSB40, 2000-09-28



<TABLE> <S> <C>

<ARTICLE>          5
<CIK>              0000722830
<NAME>             IMMUNOMEDICS, INC.
<MULTIPLIER>       1

<S>                                         <C>
<PERIOD-TYPE>                               12-MOS
<FISCAL-YEAR-END>                           JUN-30-2000
<PERIOD-START>                              JUL-01-1999
<PERIOD-END>                                JUN-30-2000
<CASH>                                         11,114,079
<SECURITIES>                                   29,751,987
<RECEIVABLES>                                     666,796
<ALLOWANCES>                                      (63,398)
<INVENTORY>                                     1,036,900
<CURRENT-ASSETS>                               43,830,457
<PP&E>                                         11,731,318
<DEPRECIATION>                                 (7,760,638)
<TOTAL-ASSETS>                                 48,026,137
<CURRENT-LIABILITIES>                           3,677,607
<BONDS>                                                 0
                                   0
                                             0
<COMMON>                                          493,291
<OTHER-SE>                                     43,602,827
<TOTAL-LIABILITY-AND-EQUITY>                   48,026,137
<SALES>                                         4,123,997
<TOTAL-REVENUES>                                5,973,455
<CGS>                                             375,076
<TOTAL-COSTS>                                  15,608,982
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                      0
<INCOME-PRETAX>                                (9,635,527)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (9,635,527)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (9,635,527)
<EPS-BASIC>                                         (0.23)
<EPS-DILUTED>                                       (0.23)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission